TRA-1-60 Monoclonal Antibody (TRA-1-60), DyLight 488 | Invitrogen MA1-023-D488X product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

Invitrogen

other brands :

NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience

product type :

antibody

product name :

TRA-1-60 Monoclonal Antibody (TRA-1-60), DyLight 488

catalog :

MA1-023-D488X

quantity :

50 uL

price :

US 440.00

clonality :

monoclonal

host :

mouse

conjugate :

DyLight488

clone name :

TRA-1-60

application :

immunocytochemistry, flow cytometry

citations: 13

Reference
Doerfler R, Melamed J, Whitehead K. The Effect of Infant Gastric Digestion on Human Maternal Milk Cells. Mol Nutr Food Res. 2022;66:e2200090 pubmed publisher
Brooks B, Pradhan M, Cheng Y, Gorshkov K, Farkhondeh A, Chen C, et al. Generation of an induced pluripotent stem cell line (TRNDi031-A) from a patient with Alagille syndrome type 1 carrying a heterozygous p. C312X (c. 936 T > A) mutation in JAGGED-1. Stem Cell Res. 2021;54:102447 pubmed publisher
Pradhan M, Farkhondeh A, Cheng Y, Xu M, Beers J, Zou J, et al. An induced pluripotent stem cell line (NCATS-CL9075) from a patient carrying compound heterozygote mutations, p.R390P and p.L318P, in the NGLY1 gene. Stem Cell Res. 2021;54:102400 pubmed publisher
Xu X, Pradhan M, Xu M, Cheng Y, Beers J, Linask K, et al. Four induced pluripotent stem cell lines (TRNDi021-C, TRNDi023-D, TRNDi024-D and TRNDi025-A) generated from fibroblasts of four healthy individuals. Stem Cell Res. 2020;49:102011 pubmed publisher
Li R, Pradhan M, Xu M, Roeder A, Beers J, Zou J, et al. An induced pluripotent stem cell line (TRNDi001-D) from a Niemann-Pick disease type C1 (NPC1) patient carrying a homozygous p. I1061T (c. 3182T>C) mutation in the NPC1 gene. Stem Cell Res. 2020;44:101737 pubmed publisher
Patterson K, Beers J, Linask K, Lin Y, Hassanzadeh S, Sack M, et al. Generation of two induced pluripotent stem cell lines (NHLBIi001-A and NHLBIi001-B) from a healthy Caucasian female volunteer with normal cardiac function. Stem Cell Res. 2019;41:101627 pubmed publisher
Baskfield A, Li R, Beers J, Zou J, Liu C, Zheng W. An induced pluripotent stem cell line (TRNDi009-C) from a Niemann-Pick disease type A patient carrying a heterozygous p.L302P (c.905 T>C) mutation in the SMPD1 gene. Stem Cell Res. 2019;38:101461 pubmed publisher
Hong J, Xu M, Li R, Cheng Y, Kouznetsova J, Beers J, et al. Generation of an induced pluripotent stem cell line (TRNDi008-A) from a Hunter syndrome patient carrying a hemizygous 208insC mutation in the IDS gene. Stem Cell Res. 2019;37:101451 pubmed publisher
Cheng Y, Li R, Baskfield A, Beers J, Zou J, Liu C, et al. A human induced pluripotent stem cell line (TRNDi007-B) from an infantile onset Pompe patient carrying p.R854X mutation in the GAA gene. Stem Cell Res. 2019;37:101435 pubmed publisher
Baskfield A, Li R, Beers J, Zou J, Liu C, Zheng W. Generation of an induced pluripotent stem cell line (TRNDi004-I) from a Niemann-Pick disease type B patient carrying a heterozygous mutation of p.L43_A44delLA in the SMPD1 gene. Stem Cell Res. 2019;37:101436 pubmed publisher
Huang W, Xu M, Li R, Baskfield A, Kouznetsova J, Beers J, et al. An induced pluripotent stem cell line (TRNDi006-A) from a MPS IIIB patient carrying homozygous mutation of p.Glu153Lys in the NAGLU gene. Stem Cell Res. 2019;37:101427 pubmed publisher
Li R, Pradhan M, Xu M, Baskfield A, Farkhondeh A, Cheng Y, et al. Generation of an induced pluripotent stem cell line (TRNDi002-B) from a patient carrying compound heterozygous p.Q208X and p.G310G mutations in the NGLY1 gene. Stem Cell Res. 2019;34:101362 pubmed publisher
Bonaventura G, Iemmolo R, D Amico A, La Cognata V, Costanzo E, Zappia M, et al. PACAP and PAC1R are differentially expressed in motor cortex of amyotrophic lateral sclerosis patients and support survival of iPSC-derived motor neurons. J Cell Physiol. 2018;233:3343-3351 pubmed publisher

product information

Product Type :

Antibody

Product Name :

TRA-1-60 Monoclonal Antibody (TRA-1-60), DyLight 488

Catalog # :

MA1-023-D488X

Quantity :

50 uL

Price :

US 440.00

Clonality :

Monoclonal

Purity :

Affinity chromatography - MBP

Host :

Mouse

Reactivity :

Human

Applications :

Flow Cytometry: 1:100, Immunocytochemistry: 1:10-1:250

Species :

Human

Clone :

TRA-1-60

Isotype :

IgM

Storage :

4 C

Description :

TRA-1-60 is a cell surface antigen, expressed along with SSEA-3, SSEA-4 and TRA-1-81 in human embryonic stem cells, embryonal carcinoma cells and induced pluripotent stem cells (iPS). These surface markers are lost during the differentiation process. In contrast, SSEA-1 is absent in undifferentiated human stem cells but is present on the cell surface after retinoic acid mediated differentiation.

Immunogen :

Human embryonal carcinoma cell line 2102Ep

Format :

Liquid

Applications w/Dilutions :

Flow Cytometry: 1:100, Immunocytochemistry: 1:10-1:250

Aliases :

TRA160; tra60